The FDA accepted a new drug application and set a review date of October 31 for Marius Pharmaceuticals’ Kyzatrex, an oral testosterone undecanoate softgel, for primary and secondary male hypogonadism.
The Endocrine Society released a new scientific statement calling for more research into the sex differences between males and females. (Endocrine Reviews)
The American Medical Association has recognized a CPT code (category III) for laser ablation of benign thyroid nodules under imaging guidance, going into effect January 2022, National Ultrasound announced.
Entera Bio’s oral human parathyroid hormone succeeded in a 6-month phase II trial at building bone in postmenopausal women with osteoporosis.
A new study found no increased cancer risk in 280 patients with acromegaly. Similar basal and current growth hormone and insulin-like growth factor 1 levels were noted in those with and without cancer. (Endocrine Practice)
The American Diabetes Association announced the recipients of its 2021 National Scientific and Health Care Achievement Awards, including Silvio Inzucchi, MD, of Yale School of Medicine, as the winner of the Outstanding Physician Clinician in Diabetes Award.
Mothers who had high exposure to the family of endocrine-disrupting chemicals PBDEs — commonly found in flame retardants — were more likely to give birth prematurely. “Although PBDE chemicals are used with good intentions, they may pose a serious health concern that may have lasting consequences for children,” said lead study author Morgan Peltier, PhD, of NYU Langone Health, in a statement. (Journal of Perinatal Medicine)
Researchers were able to grow “mini-thyroid organs” from healthy human thyroid tissue, which then formed functional hormone-producing thyroid follicles when transplanted into mice with hypothyroidism. (Stem Cell Reports)
Kristen Monaco is a staff writer, focusing on endocrinology, psychiatry, and dermatology news. Based out of the New York City office, she’s worked at the company for nearly five years.